Sana Biotechnology, Inc. - SANA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Jan 21, 2026 | SCHEDULE 13G | BlackRock, Inc. | 5.1% | 13,643,304 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | ARCH Venture Fund IX, L.P. | 17.2% | 45,860,681 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | ARCH Venture Fund IX Overage, L.P. | 17.2% | 45,860,681 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | ARCH Venture Fund X, L.P. | 17.2% | 45,860,681 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | ARCH Venture Fund X Overage, L.P. | 17.2% | 45,860,681 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | ARCH Venture Partners IX, L.P. | 17.2% | 45,860,681 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | ARCH Venture Partners IX Overage, L.P. | 17.2% | 45,860,681 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | ARCH Venture Partners X Overage, L.P. | 17.2% | 45,860,681 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | ARCH Venture Partners X, L.P. | 17.2% | 45,860,681 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | ARCH Venture Partners IX, LLC | 17.2% | 45,860,681 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | ARCH Venture Partners X, LLC | 17.2% | 45,860,681 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Keith Crandell | 17.2% | 45,860,681 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Clinton Bybee | 17.2% | 45,860,681 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Robert Nelsen | 17.3% | 46,093,125 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Steven Gillis | 17.2% | 45,860,681 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Kristina Burow | 17.2% | 45,860,681 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.